Characterization of the oligomerization defects of two p53 mutants found in families with Li-Fraumeni and Li-Fraumeni-like syndrome

Oncogene

Volumn 17, Issue 5, 1998, Pages 651-656

  Davison, Timothy S ^a   Yin, Peter ^a   Nie, Eileen ^a   Kay, Cyril ^b   Arrowsmith, Cheryl H ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

DNA binding; Li Fraumeni syndrome; Oligomerization; p53

Indexed keywords

ARGININE; CYSTEINE; LEUCINE; PROLINE; PROTEIN P53; TETRAMER;

ARTICLE; CANCER SUSCEPTIBILITY; DNA BINDING; FAMILIAL CANCER; GENE MUTATION; HUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN DOMAIN; TEMPERATURE; THERMOSTABILITY; TUMOR SUPPRESSOR GENE;

EID: 0032490855     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1202062     Document Type: Article

References (32)

1. Cariello NF, Cui L, Beroud C and Soussi T. (1994). Cancer Res., 54, 4454 - 4460.
2. Casey G, Lopez M, Ramos J, Plummer S, Arboleda M, Shaughnessy M, Karlan B and Slamon D. (1996). Oncogene, 13, 1971 - 1981.
3. Clore GM and Gronenborn AM. (1991). Science, 252, 1390 - 1399.
4. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J and Bax A. (1995). J. Biomol. NMR, 6, 277 - 293.
5. Donehower LA and Bradley A. (1993). Biochimica et Biophysica Acta, 1155, 181 - 205.
6. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW and Vogelstein B. (1993). Cell, 75, 817.
7. Harper JW, Adami GR, Wei N, Keyomarsi K and Elledge SJ. (1993). Cell, 75, 805.
8. Hollstein M, Shomer B, Greenblatt M, Soussi T, Hovig E, Montesano R and Harris CC. (1996). Nucl. Acids Res., 24, 141 - 146.
9. Hollstein M, Sidransky D, Vogelstein B and Harris CC. (1991). Science, 53, 49 - 53.
10. Hupp T, Meek D, Midgley C and Lane D. (1992). Cell, 71, 875 - 886.
11. Ishioka C, Englert C, Winge P, Yan Y-X, Engelstein M and Friend SH. (1995). Oncogene, 10, 1485 - 1492.
12. Ishioka CSH, Englert C, Shimada A, Osada M, Jia J-Q, Suzuki T, Gamo M and Kanamaru R. (1997). Biochem. Biophys. Res. Com., 232, 54 - 60.
13. Jeffrey PD, Gorina S and Pavletich NP. (1995). Science, 267, 1498.
14. Kastan MB, Zhan Q, El-Deiry WS, Carrier F, Jacks T, Walsh WV, Plunkett BS, Vogelstein B and Fornace AJ. (1992). Cell. 71, 587.
15. Ko LJ and Prives C. (1996). Genes and Dev., 10, 1054 - 1072.
16. Lee W, Harvey TS, Yin Y, Yau P, Litchfield D and Arrowsmith CH. (1994). Nat. Struct. Biol., 1, 877 - 890.
17. Levine AJ. (1997). Cell, 88, 323 - 331.
18. Lomax ME, Barnes DM, Gilchrist R, Picksley SM, Varley JM and Camplejohn RS. (1997). Oncogene, 14, 1869 - 1974.
19. Lomax ME, Barnes DM, Hupp TR, Picksley SM and Camplejohn RS. (1998). Oncogene, in press.
20. Miyashita T and Reed JC. (1995). Cell, 80, 293.
21. Pavletich NP, Chambers KA and Pabo CO. (1993). Genes and Dev., 12, 2556 - 2564.
22. Polyak K, Xia Y, Zweier J, Kinzler K and Vogelstein B. (1997). Nature, 389, 300 - 305.
23. Sambrook J, Fritsch EF and Mainiatis T. (1989). Molecular Cloning. 2nd Edition Cold Spring Harbor Laboratory Press.
24. Studier FW. (1991). J. Mol. Biol. 219, 37 - 44.
25. Tarunina M and Jenkins JR. (1993). Oncogene. 8, 3165 - 3173.
26. Vaziri H, West MD, Allsopp RC, Davison TS, Wu Y-S, Arrowsmith CH, Poirier GG and Benchimol S. (1997). EMBO J., 16, 6018 - 6033.
27. Varley JM, McGowan G, Thorncroft M, Cochrane S, Morrison P, Woll P, Kelsey AM, Mitchell ELD, Boyle J, Birch JM and Evans DGR. (1996). Oncogene, 12, 2437 - 2442.
28. Wagner P, Fuchs A, Götz C, Nastainczyk W and Montenarh M. (1998). Oncogene, 16, 105 - 111.
29. Wagner P, Fuchs A, Prowald A, Montenarh M and Nastainczyk W. (1995). FEBS Lett., 377, 155 - 158.
30. Wang P, Reed M, Wang Y, Mayr G, Stenger J, Anderson M, Schwedes J and Tegtmeyer P. (1994). Mol. Cell. and Biol., 14, 5182 - 5191.
31. Waterman JLF, Shenk JL and Halazonetis T. (1995). EMBO J., 14, 512 - 519.
32. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D. (1993). Nature, 366, 701 - 704.